$ACUR ACURA PHARMACEUTICALS, INC Insider Trading
Get free email notifications about insider trading in ACURA PHARMACEUTICALS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACURA PHARMACEUTICALS, INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ACURA PHARMACEUTICALS, INC for free.
CIK Number: 0000786947
IRS Number: 110853640
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ACUR
Company Address: 616 N. NORTH COURT, SUITE 120 . PALATINE 60067
Phone number: 847-705-7709
Former name: HALSEY DRUG CO INC/NEW, date of change: 1992-07-03
Former name: HALSEY DRUG CO INC/NEW, date of change: 1992-07-03
Market Capitalization: $10.89M
Prev close: $1.30
Average Daily Volume: 315,103
Days Low: $0.86
Year Low: $0.50
Year High: $3.52
ACURA PHARMACEUTICALS, INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | ACUR | ACURA PHARMACEUTIC ... | Schutte John | 10% Owner | Buy | C | 0.16 | 42,984,375 | 6,877,500 | 42,984,375 | 0 to 43 M |
Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.15 | 20,000 | 3,020 | 0 | |
Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Payment of Exercise | F | 0.40 | 7,550 | 3,020 | 474,042 | 481.6 K to 474 K (-1.57 %) |
Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Buy | M | 0.15 | 20,000 | 3,020 | 481,592 | 461.6 K to 481.6 K (+4.33 %) |
Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.15 | 40,000 | 6,040 | 0 | |
Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Payment of Exercise | F | 0.40 | 15,100 | 6,040 | 416,097 | 431.2 K to 416.1 K (-3.50 %) |
Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Buy | M | 0.15 | 40,000 | 6,040 | 431,197 | 391.2 K to 431.2 K (+10.23 %) |
Jan 12 2021 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
Jan 12 2021 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Buy | M | 0.00 | 54,790 | 0 | 264,315 | 209.5 K to 264.3 K (+26.15 %) |
Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | M | 0.00 | 54,790 | 0 | 312,171 | 257.4 K to 312.2 K (+21.29 %) |
Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Buy | M | 0.00 | 54,790 | 0 | 658,716 | 603.9 K to 658.7 K (+9.07 %) |
Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Buy | M | 0.00 | 54,790 | 0 | 392,657 | 337.9 K to 392.7 K (+16.22 %) |